Abstract
A series of novel dimethyl ((aryl/heteroarylamino) (4-(pyrrolidin-1-yl) phenyl)) methyl phosphonates were synthesized by simple and an efficient one-pot three component Kabachnik- Fields reaction. Pyrrolidino-4-benzaldehyde (1), different substituted amines 2a-l and dimethylphosphite (3) were reacted at room temperature using aqueous zinc tetrafluoroborate as catalyst under solvent free conditions to obtain the title compounds 4a-l. The anticancer activity was predicted by in silico studies where the best interactions were observed against aromatase, a potential cancer target and even their molecular descriptors and ADME attributes prompted them as safe drug like molecules. Their in vitro evaluation by MTT assay against human prostate cancer cells (PC-3M) revealed their potential anticancer activity when compared with the standard drug cyclophosphamide encouraging their use to control and manage prostate malignancy
Keywords: Kabachnik-Fields reaction, Pyrrolidino-4-benzaldehyde, Invitro anticancer activity, Insilico studies, PC-3M cell lines, MTT Assay.
Letters in Drug Design & Discovery
Title:Zinc Tetrafluoroborate Catalyzed Synthesis, Molecular Docking and Cytotoxicity of Pyrrolidinyl Aminophosphonates
Volume: 14 Issue: 2
Author(s): Sarva Santhisudha, Kandula Madhu Kumar Reddy, Yellapu Nanda Kumar, Ethiraj Selvarajan, Vaithiyalingam Mohanasrinivasan, Sandip Kumar Nayak and Cirandur Suresh Reddy
Affiliation:
Keywords: Kabachnik-Fields reaction, Pyrrolidino-4-benzaldehyde, Invitro anticancer activity, Insilico studies, PC-3M cell lines, MTT Assay.
Abstract: A series of novel dimethyl ((aryl/heteroarylamino) (4-(pyrrolidin-1-yl) phenyl)) methyl phosphonates were synthesized by simple and an efficient one-pot three component Kabachnik- Fields reaction. Pyrrolidino-4-benzaldehyde (1), different substituted amines 2a-l and dimethylphosphite (3) were reacted at room temperature using aqueous zinc tetrafluoroborate as catalyst under solvent free conditions to obtain the title compounds 4a-l. The anticancer activity was predicted by in silico studies where the best interactions were observed against aromatase, a potential cancer target and even their molecular descriptors and ADME attributes prompted them as safe drug like molecules. Their in vitro evaluation by MTT assay against human prostate cancer cells (PC-3M) revealed their potential anticancer activity when compared with the standard drug cyclophosphamide encouraging their use to control and manage prostate malignancy
Export Options
About this article
Cite this article as:
Santhisudha Sarva, Reddy Madhu Kumar Kandula, Kumar Nanda Yellapu, Selvarajan Ethiraj, Mohanasrinivasan Vaithiyalingam, Nayak Kumar Sandip and Reddy Suresh Cirandur, Zinc Tetrafluoroborate Catalyzed Synthesis, Molecular Docking and Cytotoxicity of Pyrrolidinyl Aminophosphonates, Letters in Drug Design & Discovery 2017; 14 (2) . https://dx.doi.org/10.2174/1570180813666160722123045
DOI https://dx.doi.org/10.2174/1570180813666160722123045 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Targeting of Chemokines with Monoclonal Antibodies
Current Immunology Reviews (Discontinued) CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling
Current Cancer Drug Targets Preparation and Surface Modification of Polymeric Nanoparticles for Drug Delivery: State of the Art
Recent Patents on Drug Delivery & Formulation Virtual Screening of Natural Products Database
Mini-Reviews in Medicinal Chemistry NF-κ B and Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Reprogrammed Metabolism of Cancer Cells as a Potential Therapeutic Target
Current Pharmaceutical Design Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform
Current Pharmaceutical Design Combined Cancer Therapy with Non-Conventional Drugs: All Roads Lead to AMPK
Mini-Reviews in Medicinal Chemistry A Review of Accelerator-Produced Ga-68 with Solid Targets
Current Radiopharmaceuticals Modified Polysaccharides as Carriers for Biomolecules
Pharmaceutical Nanotechnology Chemical Constituents of Plants from the Genus Valeriana
Mini-Reviews in Organic Chemistry Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy
Current Molecular Medicine From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Food, Nutrition & Agriculture In the Rush for Green Gold: Can Green Tea Delay Age-Progressive Brain Neurodegeneration?
Recent Patents on CNS Drug Discovery (Discontinued) Affective Disorder and Hyperandrogenism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Amygdalin Decreases Adhesion and Migration of MDA-MB-231 and MCF-7 Breast Cancer Cell Lines
Current Molecular Pharmacology Meet Our Associate Editorial Board Member
Current Pharmaceutical Biotechnology Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators
Current Topics in Medicinal Chemistry From Bacteria to Antineoplastic: Epothilones A Successful History
Anti-Cancer Agents in Medicinal Chemistry